Thiard News@F4F

@newsen.bsky.social

1 day ago

Investors Rally Behind Class Action Lawsuit Against uniQure N.V. for Securities Violations A class action lawsuit has been filed against uniQure N.V. for securities law violations. Investors are encouraged to join to recover their losses.

Investors Rally Behind Class Action Lawsuit Against uniQure N.V. for Securities Violations #USA #Securities_Law #DJS_Law_Group #Eastchester #uniQure

Thiard News@F4F

@newsen.bsky.social

1 day ago

Hagens Berman Provides Critical Update on uniQure Investigation Amid FDA Scrutiny and Class Action Suit Hagens Berman updates its investigation into uniQure following serious FDA criticisms and a class action suit. Investors must act before April 13.

Hagens Berman Provides Critical Update on uniQure Investigation Amid FDA Scrutiny and Class Action Suit #USA #San_Francisco #FDA #Hagens_Berman #uniQure

Thiard News@F4F

@newsen.bsky.social

3 days ago

Faruqi & Faruqi Urges UniQure Investors to Act Before Class Action Deadline Approaches Faruqi & Faruqi, a top law firm, highlights the approaching deadline for UniQure investors to engage in crucial securities class action by April 13, 2026.

Faruqi & Faruqi Urges UniQure Investors to Act Before Class Action Deadline Approaches #United_States #New_York #Securities_Class_Action #Faruqi_&_Faruqi #uniQure

Thiard News@F4F

@newsen.bsky.social

3 days ago

Critical Updates on uniQure (QURE) Amidst FDA Controversy and Class Action Deadline Approaching Hagens Berman intensifies its investigation into uniQure as FDA criticism raises serious concerns. A critical deadline for class action looms on April 13, ensuring investor awareness.

Critical Updates on uniQure (QURE) Amidst FDA Controversy and Class Action Deadline Approaching #Hagens_Berman #uniQure #FDA_Criticism

Thiard News@F4F

@newsen.bsky.social

4 days ago

Pomerantz Law Firm Urges uniQure Investors to Join Class Action Lawsuit Before Deadline Pomerantz LLP informs investors of a class action lawsuit against uniQure N.V., highlighting the impacts of recent developments on investors' rights and financial losses.

Pomerantz Law Firm Urges uniQure Investors to Join Class Action Lawsuit Before Deadline #USA #New_York #Pomerantz #uniQure #QURE

Thiard News@F4F

@newsen.bsky.social

5 days ago

uniQure Faces Increased Scrutiny as Hagens Berman Updates Investigation After FDA's Stark Critique Hagens Berman intensifies its investigation into uniQure following significant FDA criticism. Investors must act quickly before the April 13 deadline.

uniQure Faces Increased Scrutiny as Hagens Berman Updates Investigation After FDA's Stark Critique #United_States #San_Francisco #Hagens_Berman #uniQure #FDA_Criticism

Thiard News@F4F

@newsen.bsky.social

1 week ago

Hagens Berman Investigates uniQure Amidst FDA Criticism and Allegations of Misleading Data Hagens Berman is investigating uniQure (QURE) after significant criticism from the FDA regarding its clinical data. Investors are urged to act before the April deadline.

Hagens Berman Investigates uniQure Amidst FDA Criticism and Allegations of Misleading Data #Hagens_Berman #uniQure #AMT-130

Thiard News@F4F

@newsen.bsky.social

1 week ago

Faruqi & Faruqi Alerts uniQure Investors: Class Action Deadline Approaching Investors in uniQure N.V. are urged by Faruqi & Faruqi to act quickly. The deadline to join a federal securities class action is fast approaching on April 13, 2026.

Faruqi & Faruqi Alerts uniQure Investors: Class Action Deadline Approaching #United_States #New_York #Securities_Class_Action #Faruqi_&_Faruqi #uniQure

Thiard News@F4F

@newsen.bsky.social

1 week ago

uniQure N.V. Faces Class Action Over FDA Approval Delay and Stock Plunge uniQure N.V. investors face a class action lawsuit due to a significant stock decline after FDA approval delays. Key actions required before April 13, 2026.

uniQure N.V. Faces Class Action Over FDA Approval Delay and Stock Plunge #USA #New_York #Kahn_Swick #NV #uniQure

Thiard News@F4F

@newsen.bsky.social

1 week ago

uniQure N.V. Investors Encouraged to Pursue Securities Fraud Legal Action Investors who acquired shares of uniQure N.V. during a specified range can join a securities fraud lawsuit aimed at securing compensation without upfront costs.

uniQure N.V. Investors Encouraged to Pursue Securities Fraud Legal Action #United_States #New_York #Securities_Fraud #Rosen_Law_Firm #uniQure

Thiard News@F4F

@newsen.bsky.social

1 week ago

Hagens Berman Expands Investigation into uniQure Amid FDA Controversies and Allegations of Data Misrepresentation Hagens Berman's ongoing investigation into uniQure N.V. follows serious accusations from the FDA regarding potential data misrepresentation, impacting investors significantly.

Hagens Berman Expands Investigation into uniQure Amid FDA Controversies and Allegations of Data Misrepresentation #USA #San_Francisco #FDA #Securities_Class_Action #uniQure

Thiard News@F4F

@newsen.bsky.social

1 week ago

Class Action Lawsuit Filed Against uniQure N.V. Over Securities Fraud Allegations A class action lawsuit has been initiated against uniQure N.V. alleging securities fraud relating to its Huntington's disease treatment. Investors are urged to act.

Class Action Lawsuit Filed Against uniQure N.V. Over Securities Fraud Allegations #United_States #New_York #Kessler_Topaz #uniQure #QURE

Thiard News@F4F

@newsen.bsky.social

1 week ago

UniQure Under Scrutiny: FDA Allegations Spark Legal Action for Investors Hagens Berman escalates its investigation into uniQure, highlighting recent FDA challenges and ethical concerns surrounding data manipulations. Learn more.

UniQure Under Scrutiny: FDA Allegations Spark Legal Action for Investors #USA #San_Francisco #Hagens_Berman #uniQure #NASDAQ_QURE

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Opportunity for QURE Investors to Lead a Major Securities Fraud Case Against uniQure N.V. Investors in uniQure N.V. can join a class action lawsuit over securities fraud, potentially receiving compensation without upfront costs.

Opportunity for QURE Investors to Lead a Major Securities Fraud Case Against uniQure N.V. #USA #New_York #Securities_Fraud #Investor_Rights #uniQure

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Faruqi & Faruqi Alerts UniQure Investors on Class Action Deadline Set for April 2026 Faruqi & Faruqi, LLP calls on UniQure investors to take action as the deadline for a securities class action lawsuit approaches on April 13, 2026.

Faruqi & Faruqi Alerts UniQure Investors on Class Action Deadline Set for April 2026 #None #Securities_Class_Action #Faruqi_&_Faruqi #uniQure

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

uniQure Faces Legal Scrutiny After Allegations of Regulatory Misconduct Hagens Berman is closely examining uniQure N.V. after serious FDA allegations against its gene therapy AMT-130. Investors face a looming lawsuit deadline.

uniQure Faces Legal Scrutiny After Allegations of Regulatory Misconduct #USA #San_Francisco #Hagens_Berman #uniQure #AMT-130

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Investors Encouraged to Join uniQure N.V. Securities Fraud Class Action Lawsuit The Schall Law Firm is urging investors of uniQure N.V. to participate in a class action lawsuit over securities fraud allegations, particularly for those affected between September and October 2025.

Investors Encouraged to Join uniQure N.V. Securities Fraud Class Action Lawsuit #USA #Los_Angeles #Schall_Law_Firm #uniQure #NASDAQ_QURE

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Class Action Lawsuit Filed Against uniQure N.V. by Pomerantz Law Firm with Important Deadlines Ahead Pomerantz Law Firm has initiated a class action lawsuit against uniQure N.V. Investors with losses are encouraged to participate promptly before key deadlines.

Class Action Lawsuit Filed Against uniQure N.V. by Pomerantz Law Firm with Important Deadlines Ahead #USA #New_York #Pomerantz_Law #uniQure #QURE

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Hagens Berman Informs on uniQure Investigation Amid FDA Controversies Hagens Berman updates its investigation into uniQure following serious allegations from the FDA about distorted data in clinical trials and significant legal deadlines.

Hagens Berman Informs on uniQure Investigation Amid FDA Controversies #FDA #Hagens_Berman #uniQure

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Levi & Korsinsky Alerts uniQure Shareholders About Class Action Lawsuit Deadline Levi & Korsinsky informs uniQure investors of a class action lawsuit with a lead plaintiff deadline of April 13, 2026, regarding alleged securities fraud.

Levi & Korsinsky Alerts uniQure Shareholders About Class Action Lawsuit Deadline #None #Class_Action #Securities_Fraud #uniQure

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

uniQure Investors Alert: Securities Class Action Deadline Approaches in 2026 Faruqi & Faruqi, LLP reminds uniQure investors of the urgent deadline for a securities class action. Claims must be filed by April 13, 2026.

uniQure Investors Alert: Securities Class Action Deadline Approaches in 2026 #None #Faruqi_&_Faruqi #Securities_Class #uniQure

Thiard News@F4F

@newsen.bsky.social

3 weeks ago

Investors with Losses Encouraged to Join uniQure Class Action Lawsuit uniQure N.V. shareholders have the opportunity to lead a class action lawsuit following alleged misleading statements. Act before the April deadline.

Investors with Losses Encouraged to Join uniQure Class Action Lawsuit #United_States #New_York #Class_Action #securities_lawsuit #uniQure

Thiard News@F4F

@newsen.bsky.social

3 weeks ago

Investors of uniQure N.V. Urged to Step Forward for Class Action Lawsuit uniQure N.V. shareholders are reminded to join a class-action lawsuit aimed at addressing potential securities fraud, with an April 2026 deadline looming.

Investors of uniQure N.V. Urged to Step Forward for Class Action Lawsuit #USA #New_York #Rosen_Law_Firm #uniQure #NASDAQ_QURE

Thiard News@F4F

@newsen.bsky.social

3 weeks ago

uniQure N.V. Faces Securities Fraud Class Action After FDA Delay Triggers 49% Stock Price Drop uniQure N.V. is embroiled in a securities fraud class action lawsuit following a significant decline in stock value after an FDA approval delay. Investors can reach out to KSF for guidance.

uniQure N.V. Faces Securities Fraud Class Action After FDA Delay Triggers 49% Stock Price Drop #USA #New_York #NASDAQ #uniQure #QURE

Thiard News@F4F

@newsen.bsky.social

3 weeks ago

Federal Officials Accuse uniQure of Misleading Data in AMT-130 Drug Controversy uniQure is facing serious allegations from federal health officials regarding manipulated data for its AMT-130 drug, amid a class action lawsuit.

Federal Officials Accuse uniQure of Misleading Data in AMT-130 Drug Controversy #FDA #uniQure #AMT-130

Thiard News@F4F

@newsen.bsky.social

3 weeks ago

uniQure Investors Notified of Class Action Deadline by Faruqi & Faruqi, LLP uniQure N.V. shareholders are reminded of the approaching class action deadline on April 13, 2026, as detailed by Faruqi & Faruqi, LLP.

uniQure Investors Notified of Class Action Deadline by Faruqi & Faruqi, LLP #USA #New_York #Securities_Class_Action #Faruqi_&_Faruqi #uniQure

Thiard News@F4F

@newsen.bsky.social

4 weeks ago

Concerns Rise as FDA Criticizes uniQure's AMT-130 Data and Seeks Accountability The FDA has publicly criticized uniQure's clinical data on AMT-130, leading to a pending securities class action. The backlash raises investor concerns regarding transparency and accountability.

Concerns Rise as FDA Criticizes uniQure's AMT-130 Data and Seeks Accountability #United_States #San_Francisco #FDA #uniQure #AMT-130

Thiard News@F4F

@newsen.bsky.social

1 month ago

uniQure Investors Alert: Class Action Suit Deadline Approaches for Significant Financial Losses Investors with losses exceeding $100,000 from uniQure N.V. have until April 13, 2026, to apply as lead plaintiff in a class action suit. Act now!

uniQure Investors Alert: Class Action Suit Deadline Approaches for Significant Financial Losses #United_States #New_Orleans #ClaimsFiler #uniQure #AMT-130

@pharmalot.bsky.social

1 month ago

Pharmalittle: We're reading about an FDA-UniQure tussle, a Pfizer obesity drug approval in China, and more China has approved a new obesity treatment from Pfizer, heightening competition in a market poised to become even more crowded

Pharmalot.. Pharmalittle.. Good Morning: We’re reading about an FDA-UniQure tussle, a Pfizer obesity drug approval in China, and more news.. statnews.com/pharmalot/20... #pharma #FDA #UniQure #China #Pfizer #obesity #antibiotics

Thiard News@F4F

@newsen.bsky.social

1 month ago

Investors Must Act Now: Important Deadlines for uniQure Securities Class Action in April 2026 A crucial date approaches for investors in uniQure N.V. as a securities class action is underway. Learn how to engage in this legal process.

Investors Must Act Now: Important Deadlines for uniQure Securities Class Action in April 2026 #United_States #New_York #Securities_Class_Action #Faruqi_&_Faruqi #uniQure